Nuvation Bio (NUVB) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
21 May, 2026Opening remarks and agenda
Meeting commenced at 11:00 A.M. ET, hosted virtually and recorded for future access.
Board members, legal counsel, and independent auditors were introduced.
The agenda included three proposals: director elections, auditor ratification, and executive compensation approval.
Board and executive committee updates
Board members present included David Hung, Robert Bazemore, Kim Blickenstaff, Min Cui, Kathryn Falberg, Robert Mashal, and Anthony Vernon.
KPMG LLP and Cooley LLP representatives attended virtually to address questions.
Shareholder proposals
Three proposals: election of directors, ratification of KPMG LLP as auditor for 2026, and advisory approval of executive compensation.
Director nominees: Robert B. Bazemore Jr. and Robert Mashal (Class A & B), Kim Blickenstaff (Class B).
Latest events from Nuvation Bio
- IBTROZI's rapid first-line growth and robust pipeline drive strong outlook and financial stability.NUVB
7th Annual Oncology Innovation Summit: Insights for ASCO & EHA26 May 2026 - IBTROZI and safusidenib drive growth with best-in-class data and major upcoming clinical catalysts.NUVB
H.C. Wainwright 4th Annual BioConnect Investor Conference22 May 2026 - First-line growth, new testing mandates, and pipeline advances position for multibillion-dollar markets.NUVB
RBC Capital Markets Global Healthcare Conference 202620 May 2026 - ZUSDURI sees rapid adoption and durable results, fueling growth and pipeline expansion.NUVB
Bank of America Global Healthcare Conference 202613 May 2026 - Ibtrozi's first-line growth and Eisai deal drive strong Q1 2026 results and global expansion.NUVB
Q1 202610 May 2026 - IBTROZI drives strong growth in ROS1+ NSCLC as safusidenib and DDCs advance in oncology.NUVB
Investor presentation4 May 2026 - First-line patient growth and robust pipeline drive strong outlook and international expansion.NUVB
TD Cowen 46th Annual Health Care Conference29 Apr 2026 - IBTROZI sets a new standard in ROS1+ NSCLC with high efficacy, safety, and rapid adoption.NUVB
Corporate presentation22 Apr 2026 - Director compensation figures for 2025 were corrected, clarifying cash and option awards.NUVB
Proxy filing21 Apr 2026